Safety and Quality > Our Work > Healthcare Associated Infection > National Surveillance Initiative

The National Surveillance Initiative seeks to explore options for a national surveillance system to monitor healthcare associated infections (HAI) and provide timely feedback to jurisdictions and clinicians. The result is an evidence-based and authoritative analysis that can promote stronger linkages between other health data systems and with policy makers, and to ensure that the messages derived from surveillance data can be turned into public health action for better health outcomes.

Surveillance Validation Guide for healthcare associated Staphylococcus aureus Bloodstream Infection (PDF 1.20MB) (Word 864KB)

Latest data

Healthcare-associated Staphylococcus aureus bloodstream infections, 2013–14:

Reducing harm to patients from healthcare associated infection: the role of surveillance

A report, Reducing harm to patients from healthcare associated infection: the role of surveillance, was compiled by 51 experts from across Australia. This report provides an overview of current HAI issues and surveillance initiatives in Australia and a review of international and Australian surveillance literature. Providing a comprehensive picture of the surveillance of HAI in Australia, the report demonstrates the costs that these infections impose upon individual Australians and the health system.

Implementation Guides for SAB, CDI and CLABSI

Three implementation guides have been developed for use by Australian hospitals and organisations to support the implementation of surveillance for Staphylococcus aureus bacteraemia (SAB), Clostridium difficile infection (CDI) and Central Line Associated Bloodstream Infections (CLABSI). The guides have been developed by the Commission’s Healthcare Associated Infection Technical Advisory Group in collaboration with the clinical experts and the surveillance units from jurisdictions and are designed to support and standardise existing surveillance activities in line with the national definitions for SAB, CDI and CLABSI.

Each of the guides detail interpretation of the definitions, flowcharts, inclusions and exclusion for each of the surveillance topics, as well a list of examples to assist with decisions on those more difficult cases. The guides are not intended to replace or inform clinical management of infections or patient management but to standardise how key infection data is collected and reported. All comments and feedback will be reviewed and responded to as part of the consultation process.

Comments and feedback received will be reviewed and responded to monthly by the HAI Technical Working Group.

Below are links to the implementation guides:

For more information contact HAI@safetyandquality.gov.au

National Definitions and Calculations